Clinical Trials on Angiocentric Glioma

Total 2917 results

Children's Oncology Group
National Cancer Institute (NCI)

Completed

Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma

Brain Tumors | Central Nervous System Tumors

United States, Canada, Netherlands, Puerto Rico, Switzerland
Duke University
Genentech, Inc.; Schering-Plough

Completed

Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas

Glioblastoma | Brain Tumor | Gliosarcoma

United States
Children's Cancer and Leukaemia Group

Unknown

High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma

Brain and Central Nervous System Tumors

United Kingdom, Ireland
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma

Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System

United States
Duke University
National Cancer Institute (NCI); Novartis Pharmaceuticals

Completed

Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma

Glioblastoma | Gliosarcoma

United States
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Completed

Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma

Brain and Central Nervous System Tumors

United States
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma

Brain and Central Nervous System Tumors

United States
Cedars-Sinai Medical Center

Completed

The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function

Breast Cancer | Glioblastoma | Colorectal Cancer | Lung Cancer

United States
Lawrence Recht
National Cancer Institute (NCI)

Completed

Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma

Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult Ependymoblastoma | Adult Medulloblastoma | Adult Pineoblastoma | Adult Supratentorial Primitive Neuroectodermal Tumor (PNET) | Adult Oligodendroglial Tumors

United States
National Health Research Institutes, Taiwan

Recruiting

A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma

Primary Malignant Brain Tumors

Taiwan
Henan Provincial People's Hospital

Not yet recruiting

Correlation Between Psychological Stress and Progression of Newly Oligodendroglioma Towards Secondary Glioma

Oligodendroglioma, Adult
Henan Provincial People's Hospital

Not yet recruiting

Correlation Between Psychological Stress and Progression of Diffuse Astrocytoma Towards Secondary Glioma

Astrocytoma

China
Mayo Clinic
Merck Sharp & Dohme LLC; NeoImmune Tech

Recruiting

Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

Recurrent Glioblastoma, IDH-Wildtype | Recurrent Gliosarcoma | High Grade Astrocytic Tumor

United States
University of Maryland, Baltimore
Keep Punching Foundation

Recruiting

LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)

Glioma | Glioblastoma | Brain Tumor

United States
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University

Active, not recruiting

Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers

Glioblastoma | Brain Cancer

United States
Proximagen, LLC

Terminated

Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM)

Solid Tumors (Phase 1) | Relapsed/Recurrent GBM (Phase 2)

United States, Spain
Gary Archer Ph.D.
National Cancer Institute (NCI)

Completed

Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia (REGULATe)

Malignant Neoplasms Brain

United States
The Leeds Teaching Hospitals NHS Trust

Unknown

Multi-parametric MRI/Fluorine-18 Fluciclovine PET-CT in Glioblastoma

Tumor, Brain

United Kingdom
M.D. Anderson Cancer Center
Direct Therapeutics

Completed

Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas

Glioma | Brain Neoplasms

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma

Brain Tumor | Central Nervous System Tumors

United States
Memorial Sloan Kettering Cancer Center
Columbia University

Completed

[18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors

Brain Cancer | Gliomas

United States
Massachusetts General Hospital

Not yet recruiting

Long-term Follow-up of Subjects Treated With CARv3-TEAM-E T Cells

Glioblastoma Recurrent, EGFR vIII Mutant | Newly Diagnosed Glioblastoma, EGFRvIII Mutant | Recurrent Glioblastoma, EGFR vIII Negative

United States
Nader Sanai
Novartis; Barrow Neurological Institute; Ivy Brain Tumor Center

Active, not recruiting

Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients

Glioblastoma Multiforme | Meningioma

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Active, not recruiting

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Glioblastoma | Chemoradiation | Cognitive Decline | Radiotherapy; Complications

United States, Guam
Assistance Publique - Hôpitaux de Paris

Completed

Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed Environment (IDeATIon)

Glioma | Non Small Cell Lung Cancer | Non Hodgkin Lymphoma

France
University of Alabama at Birmingham

Completed

A Phase I Study of ABT 510 for Newly Diagnosed Glioblastoma Multiforme

Brain Tumor

United States
Mingge LLC
Fudan University; Huashan Hospital

Enrolling by invitation

MRI-based Computer Aided Diagnosis Software (V1) for Glioma

Glioma | Primary Brain Tumor

China
Memorial Sloan Kettering Cancer Center

Completed

Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas

Brain Cancer

United States
Karolinska Institutet
Karolinska University Hospital

Completed

Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection

Glioblastoma Multiforme | Cytomegalovirus Infection

Sweden
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors

Recurrent Childhood Medulloblastoma | Recurrent Ependymoma | Recurrent Medulloblastoma

United States
Children's Hospital of Philadelphia
Emory University; Stanford University

Terminated

Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed Medulloblastoma

Medulloblastoma | Brain Tumors | Central Nervous System Tumors

United States
European Organisation for Research and Treatment...
NCIC Clinical Trials Group; Trans Tasman Radiation Oncology Group; British Medical...

Completed

Radiation Therapy or Temozolomide in Treating Patients With Gliomas

Brain and Central Nervous System Tumors

France, Spain, Canada, Italy, United Kingdom, Australia, Netherlands, Belgium, Germany, Egypt, Sweden, New Zealand, Israel, Hungary, Singapore, Switzerland, Austria, Luxembourg, Portugal
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Study of Tissue and Blood Samples From Patients With Low-Grade Glioma

Brain and Central Nervous System Tumors

United States
University of Alabama at Birmingham

Completed

A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme Patients (BEAM)

Brain Cancer

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma

Brain and Central Nervous System Tumors

United States, Canada, Australia, Switzerland, Puerto Rico, Netherlands, New Zealand
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas

Brain and Central Nervous System Tumors

United States
Societe Internationale d'Oncologie Pediatrique

Unknown

Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma

Brain and Central Nervous System Tumors

United Kingdom, Italy, Germany
Children's Cancer and Leukaemia Group

Unknown

Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma

Brain and Central Nervous System Tumors

United Kingdom, Ireland
St. Jude Children's Research Hospital

Completed

Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma

Brain and Central Nervous System Tumors

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas

Brain and Central Nervous System Tumors

United States
Pharmacyclics LLC.

Completed

A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas

Glioma | Glioblastoma | Astrocytoma | Brain Neoplasm | Oligodendroglioma

United States
Maastricht Radiation Oncology
University Medical Center Groningen; Erasmus Medical Center; Leiden University... and other collaborators

Recruiting

Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology

Astrocytoma | Adenoma | Ependymoma | Nerve Sheath Neoplasms | Ganglioglioma | Oligodendroglioma | Meningioma | Hemangiopericytoma | Craniopharyngioma | Germinoma | Neurilemmoma | Optic Nerve Glioma

Netherlands
National Cancer Institute (NCI)

Recruiting

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Glioma | Ependymoma | Medulloblastoma

United States
National Cancer Institute (NCI)

Recruiting

Study of Zotiraciclib for Recurrent High-Grade Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

Cancer | Brain Tumor

United States
University of Alabama at Birmingham
In8bio Inc.

Active, not recruiting

Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma (DRI)

Brain Tumor Adult

United States
Giselle Sholler
K C Pharmaceuticals Inc.; USWM, LLC

Available

An Intermediate Expanded Use Trial of DFMO

Embryonal Tumor With Abundant Neuropil and True Rosettes | Medulloblastoma | Neuroblastoma | Medulloepithelioma | Ependymoblastoma | Typical Teratoid Rhabdoid Tumor

United States
M.D. Anderson Cancer Center

Completed

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

Glioblastoma | Brain Cancer

United States
Alliance for Clinical Trials in Oncology
Bristol-Myers Squibb; National Cancer Institute (NCI)

Completed

Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
University of Wisconsin, Madison
National Cancer Institute (NCI)

Completed

PET/CT Imaging of Malignant Brain Tumors With 124I-NM404

Glioblastoma | Brain Metastases

United States
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology; Eastern Cooperative Oncology Group and other collaborators

Completed

Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas

Brain and Central Nervous System Tumors

United States

Clinical Trials on Angiocentric Glioma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations